March 11, 2021
Tvardi Therapeutics Appoints Michael Wyzga, Former CFO of Genzyme, to Board of Directors

January 28, 2021
Tvardi Therapeutics Appoints Sujal Shah To Board of Directors

November 20, 2020
Tvardi Therapeutics Awarded Most Promising Company

June 03, 2020
KRLD Radio Interview: Some Covid Survivors Face Long-Term Consequences

June 01, 2020
Pharmacokinetics and pharmacodynamics of TTI-101, a STAT3 inhibitor that blocks muscle proteolysis in rats with chronic kidney disease

April 09, 2020
Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution